U.S. Near Infrared Imaging Market Summary

The U.S. near infrared (NIR) imaging market size was valued at USD 763.4 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2030. Several key drivers are fueling this growth, including the increasing geriatric population, a growing demand for minimally invasive surgical procedures, and the broad range of benefits provided by NIR imaging technologies. Additionally, the rising number of surgical interventions required due to the high prevalence of chronic and acute target diseases is expected to further create opportunities for market expansion during the forecast period.

The growing burden of diseases such as cardiovascular disorders, cancer, neurovascular diseases, and gastrointestinal complications is resulting in a significant rise in the number of surgical procedures across the country. Alongside these conditions, the growing number of trauma-related injuries and the increasing popularity of cosmetic and reconstructive surgeries are also contributing to market demand. NIR imaging technology is gaining wide applicability across multiple surgical domains, including cancer-related surgeries, plastic and reconstructive surgeries, cardiothoracic surgeries, gastrointestinal interventions, cardiovascular treatments, and neurovascular surgeries, owing to its high precision, safety, and efficiency.

Key Market Trends & Insights

• From a product perspective, reagents dominated the market with the largest revenue share of 56% in 2023 and are forecasted to grow at the fastest CAGR during the study period. The increasing dominance of reagents can be attributed to their ability to provide higher detection efficiency within biological systems, their strong tissue penetration capacity, and the detailed imaging outcomes they offer. These advantages have led to their growing adoption across research laboratories, hospitals, and pharmaceutical companies.
• In terms of application, preclinical imaging accounted for the largest market share of 25% in 2023. This segment’s growth is primarily driven by the increasing number of preclinical studies focusing on targeted diseases, particularly cancer, infectious diseases, and inflammatory disorders. The use of NIR imaging in these studies allows researchers to better understand disease mechanisms, evaluate the effectiveness of new therapies, and track disease progression in non-invasive ways, making it a vital tool in biomedical research.
• Based on end-use segmentation, hospitals and clinics emerged as the leading segment with a 44% share of the U.S. NIR imaging market in 2023. This dominance can be attributed to the high prevalence of cancer surgeries, cosmetic procedures, and reconstructive surgeries that rely on NIR imaging systems. Furthermore, hospitals are adopting NIR technologies for additional uses, such as detecting bedsores and preventing surgical errors, which further boosts the adoption rate in this segment.
• Meanwhile, the pharmaceutical and biotechnology companies’ segment is projected to expand at a significant CAGR between 2024 and 2030. NIR technology is extensively utilized in this sector for several purposes, including raw material identification, verification of lyophilized products, monitoring of tablet coatings and drug content uniformity, supervision of fermentation and cell culture processes, and real-time in-line and on-line monitoring during pharmaceutical manufacturing. These diverse applications are expected to drive substantial demand for NIR systems in pharmaceutical and biotech companies in the coming years.

Order a free sample PDF of the U.S. Near Infrared Imaging Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 763.4 million
• 2030 Projected Market Size: USD 1.0 billion
• CAGR (2024 - 2030): 4.0%

Key Companies & Market Share Insights

Leading U.S. near-infrared imaging companies include Stryker, PerkinElmer, Inc., Li-Cor, Inc., PerkinElmer, Inc., Leica Microsystems, and Intuitive Surgical among others.

These Companies focus on developing and upgrading existing technologies to enhance patient outcomes and significantly increase healthcare effectiveness Moreover, M&A activities undertaken by market players, innovative product launches and regional product expansion initiatives further leverage the growth of the market.

Key Players

• Stryker
• PerkinElmer, Inc
• Li-Cor, Inc.
• PerkinElmer, Inc.
• Leica Microsystems
• Intuitive Surgical
• Avantor®
• ICG Pharmaceutical 
• Veranova
• CalBiotech

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. near infrared imaging market is expected to witness steady growth, supported by rising demand for minimally invasive surgeries, the growing geriatric population, and increasing adoption across hospitals, clinics, and pharmaceutical companies. Reagents continue to dominate due to their superior imaging efficiency, while preclinical studies drive application growth. Hospitals remain the leading end-use segment, with biotechnology firms rapidly integrating NIR systems for quality control and research purposes. With broad applicability in clinical, diagnostic, and research settings, combined with continuous technological innovation, the market is positioned for sustainable growth and will remain an essential part of advancing modern healthcare practices.